Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3CNS 3Lymphoid 2Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Head & Neck 1Classical hematology 1Breast 1

Conditions

Thrombocytopenia 4Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Blast Crisis 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Myeloproliferative Disorders 3Myelodysplastic-Myeloproliferative Diseases 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Leukemia 3Fanconi Anemia, Complementation Group D1 3Breast Neoplasms 3Anemia, Refractory, with Excess of Blasts 3Prostatic Neoplasms 2Primary Myelofibrosis 2Lymphoma, Non-Hodgkin 2Lymphoma 2Leukemia, Promyelocytic, Acute 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Intraocular Lymphoma 2Congenital Abnormalities 2Anemia 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Uveal Melanoma 1Triple Negative Breast Neoplasms 1Thrombocytosis 1

Interventions

pegfilgrastim 2Epoetin Alfa 2Cisplatin 2sodium thiosulfate 1etoposide phosphate 1Rituximab 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Erythropoietin 1Docetaxel 1Darbepoetin alfa 1Cytarabine 1Cyclophosphamide 1Carboplatin 1Brachytherapy 12,2'-dithiodiethanesulfonic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Carboplatin × Classical hematology × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡